Souhaitez-vous accéder aux communiqués récents ?

Zug, Switzerland, February 4, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage biopharmaceutical company dedicated to developing therapeutics that address important unmet medical...

Zug, Switzerland, January 14, 2015 - Auris Medical Holding AG (NASDAQ: EARS) today announced that it has enrolled the first 150 patients with post-acute tinnitus in Stratum B of the Company's...

Auris Medical Holding AG Reports Third Quarter 2014 Financial Results and Provides Business Update Zug, Switzerland, December 3, 2014 - Auris Medical Holding AG (NASDAQ: EARS) today provided an...

Zug, Switzerland, December 1, 2014 - Auris Medical Holding AG (NASDAQ: EARS) today announced that it will release its financial results for the third quarter ended September 30, 2014, on...

Zug, Switzerland, September 15, 2014 - Auris Medical Holding AG (NASDAQ: EARS) today provided an update on the Company's business and announced financial results for the second quarter ended June...

Zug, Switzerland, September 8, 2014 - Auris Medical Holding AG (NASDAQ: EARS) today announced that it will release its financial results for the second quarter ended June 30, 2014, on Monday,...

Zug, Switzerland, August 19, 2014 - Auris Medical Holding AG (NASDAQ: EARS) announced today that the underwriters of its initial public offering have exercised their over-allotment option to...

Zug, Switzerland, August 11, 2014 - Auris Medical Holding AG announced today the closing of its previously announced initial public offering of 9,400,000 of its ordinary shares at an initial public...

Zug, Switzerland, August 5, 2014 - Auris Medical Holding AG announced today the pricing of its initial public offering of 9,400,000 of its common shares at an initial public offering price of USD...

Zug, Switzerland, July 21, 2014 - Auris Medical Holding AG announced today that it has commenced the underwritten initial public offering of 6,900,000 of its common shares (Offering) pursuant to a...